Discovery of Lead Compounds which Modulate Tumor Specific Pyruvate Kinase M2 Acti

$19,148R03FY2008MHNIH

Massachusetts Institute Of Technology, Cambridge MA

Investigators

Matthew G. Vander Heidencontact

Linked publications & trials

Paper 22922757 Paper 22052977 Paper 20451379 Paper 20017496

View original record on NIH RePORTER →